Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-04

Clinical Trial Update: Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants [NA]

View source ↗

Summary

A completed clinical trial assessing whether galactooligosaccharides affect the incidence of atopic manifestations (including atopic dermatitis) in infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galactooligosaccharides (galactooligosaccharide)

Snippet

Sponsor: Humana Co.Ltd. | Conditions: Atopic Dermatitis | NA | Status: COMPLETED